During the past decade, Centralny Szpital Kliniczny MSW Klinika Dermatologii conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centralny Szpital Kliniczny MSW Klinika Dermatologii" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centralny Szpital Kliniczny MSW Klinika Dermatologii" are "Atopic Dermatitis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Centralny Szpital Kliniczny MSW Klinika Dermatologii" in a lesser frequency.

Most popular intervention types in "Centralny Szpital Kliniczny MSW Klinika Dermatologii" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (1 trials), "Mirikizumab" (1 trials), "Placebo" (1 trials) and "Topical corticosteroid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centralny Szpital Kliniczny MSW Klinika Dermatologii" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centralny Szpital Kliniczny MSW Klinika Dermatologii". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centralny Szpital Kliniczny MSW Klinika Dermatologii, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centralny Szpital Kliniczny MSW Klinika Dermatologii, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".